GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Other Current Payables

LungLife AI (LSE:LLAI) Other Current Payables : £0.00 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is LungLife AI Other Current Payables?

LungLife AI's Other Current Payables for the quarter that ended in Jun. 2024 was £0.00 Mil.

LungLife AI's quarterly Other Current Payables stayed the same from Jun. 2023 (£0.00 Mil) to Dec. 2023 (£0.00 Mil) but then increased from Dec. 2023 (£0.00 Mil) to Jun. 2024 (£0.00 Mil).


LungLife AI Other Current Payables Historical Data

The historical data trend for LungLife AI's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LungLife AI Other Current Payables Chart

LungLife AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Payables
Get a 7-Day Free Trial - - - - -

LungLife AI Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

LungLife AI Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


LungLife AI Other Current Payables Related Terms

Thank you for viewing the detailed overview of LungLife AI's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


LungLife AI Business Description

Traded in Other Exchanges
Address
2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320
LungLife AI Inc is focused on a developing clinical diagnostic solutions for lung cancer. The Company generates revenue from People's Republic of China and also has its presence in the United States of America.

LungLife AI Headlines

No Headlines